Skip to content


Delta-cortef, Meti-derm, Sterane (prednisolone) is a small molecule pharmaceutical. Prednisolone was first approved as Delta-cortef on 1982-01-01. It is used to treat adrenal insufficiency, ankylosing spondylitis, asthma, atopic dermatitis, and berylliosis amongst others in the USA. The pharmaceutical is active against glucocorticoid receptor. In addition, it is known to target mineralocorticoid receptor, nuclear receptor subfamily 1 group I member 2, and Ancestral Glucocorticoid Receptor2.
Trade Name Delta-cortef, Meti-derm, Sterane
Common Name Prednisolone
Indication adrenal insufficiency, ankylosing spondylitis, asthma, atopic dermatitis, berylliosis, brain neoplasms, collagen diseases, conjunctivitis, dermatitis herpetiformis, edema, erythema multiforme, hemolytic anemia, hypercalcemia, inflammation, leukemia, multiple sclerosis, mycosis fungoides, nephrotic syndrome, pemphigus, pulmonary tuberculosis, rheumatic diseases, sarcoidosis, serum sickness, synovitis, systemic lupus erythematosus, thrombocytopenia, thyroiditis, ulcerative colitis, uveitis
Drug Class Prednisone and prednisolone derivatives
Get full access now